Free Trial
NASDAQ:TENX

Tenax Therapeutics (TENX) Stock Price, News & Analysis

Tenax Therapeutics logo
$5.92 +0.16 (+2.69%)
Closing price 07/9/2025 02:43 PM Eastern
Extended Trading
$5.93 +0.01 (+0.25%)
As of 08:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Tenax Therapeutics Stock (NASDAQ:TENX)

Key Stats

Today's Range
$5.76
$5.97
50-Day Range
$5.36
$6.25
52-Week Range
$2.80
$7.89
Volume
8,422 shs
Average Volume
160,866 shs
Market Capitalization
$24.55 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$17.50
Consensus Rating
Buy

Company Overview

Tenax Therapeutics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
25th Percentile Overall Score

TENX MarketRank™: 

Tenax Therapeutics scored higher than 25% of companies evaluated by MarketBeat, and ranked 813th out of 920 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Tenax Therapeutics has received a consensus rating of Buy. The company's average rating score is 3.25, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Tenax Therapeutics has only been the subject of 1 research reports in the past 90 days.

  • Read more about Tenax Therapeutics' stock forecast and price target.
  • Earnings Growth

    Earnings for Tenax Therapeutics are expected to decrease in the coming year, from ($0.88) to ($3.30) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Tenax Therapeutics is -2.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Tenax Therapeutics is -2.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Tenax Therapeutics has a P/B Ratio of 0.22. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Tenax Therapeutics' valuation and earnings.
  • Percentage of Shares Shorted

    8.58% of the float of Tenax Therapeutics has been sold short.
  • Short Interest Ratio / Days to Cover

    Tenax Therapeutics has a short interest ratio ("days to cover") of 14.6, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Tenax Therapeutics has recently increased by 0.29%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Tenax Therapeutics does not currently pay a dividend.

  • Dividend Growth

    Tenax Therapeutics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    8.58% of the float of Tenax Therapeutics has been sold short.
  • Short Interest Ratio / Days to Cover

    Tenax Therapeutics has a short interest ratio ("days to cover") of 14.6, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Tenax Therapeutics has recently increased by 0.29%, indicating that investor sentiment is decreasing.
    • Insider Buying vs. Insider Selling

      In the past three months, Tenax Therapeutics insiders have not sold or bought any company stock.

    • Percentage Held by Insiders

      Only 3.14% of the stock of Tenax Therapeutics is held by insiders.

    • Percentage Held by Institutions

      Only 1.67% of the stock of Tenax Therapeutics is held by institutions.

    • Read more about Tenax Therapeutics' insider trading history.
    Receive TENX Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for Tenax Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

    TENX Stock News Headlines

    TENX Tenax Therapeutics, Inc. - Seeking Alpha
    AI Meltdown Imminent: Dump These Stocks Now!
    If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new invention… This could send many popular AI stocks crashing, including Nvidia. And it could happen starting as soon as June 1st.
    Tenax Therapeutics Inc.
    Tenax Therapeutics reports Q4 EPS (18c), consensus (43c)
    See More Headlines

    TENX Stock Analysis - Frequently Asked Questions

    Tenax Therapeutics' stock was trading at $6.19 at the beginning of the year. Since then, TENX stock has decreased by 4.4% and is now trading at $5.9150.

    Tenax Therapeutics, Inc. (NASDAQ:TENX) announced its earnings results on Wednesday, May, 14th. The specialty pharmaceutical company reported ($0.28) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.48) by $0.20.

    Shares of Tenax Therapeutics reverse split on Wednesday, January 3rd 2024.The 1-80 reverse split was announced on Wednesday, January 3rd 2024. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, January 3rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.

    Shares of TENX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

    Based on aggregate information from My MarketBeat watchlists, some other companies that Tenax Therapeutics investors own include Sangamo Therapeutics (SGMO), NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), CymaBay Therapeutics (CBAY), Broadcom (AVGO) and Novo Nordisk A/S (NVO).

    Company Calendar

    Last Earnings
    5/14/2025
    Today
    7/09/2025
    Next Earnings (Estimated)
    8/12/2025
    Fiscal Year End
    12/31/2025

    Industry, Sector and Symbol

    Stock Exchange
    NASDAQ
    Sector
    Medical
    Industry
    MED - BIOMED/GENE
    Sub-Industry
    Pharmaceutical Products
    Current Symbol
    NASDAQ:TENX
    CIK
    34956
    Employees
    9
    Year Founded
    1967

    Price Target and Rating

    High Price Target
    $20.00
    Low Price Target
    $15.00
    Potential Upside/Downside
    +195.9%
    Consensus Rating
    Buy
    Rating Score (0-4)
    3.25
    Research Coverage
    4 Analysts

    Profitability

    Trailing P/E Ratio
    N/A
    Forward P/E Ratio
    N/A
    P/E Growth
    N/A
    Net Income
    -$17.60 million
    Pretax Margin
    N/A

    Debt

    Sales & Book Value

    Annual Sales
    N/A
    Price / Cash Flow
    N/A
    Book Value
    $26.99 per share
    Price / Book
    0.22

    Miscellaneous

    Free Float
    4,018,000
    Market Cap
    $24.55 million
    Optionable
    Not Optionable
    Beta
    1.61

    Social Links

    7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

    Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

    Get This Free Report

    This page (NASDAQ:TENX) was last updated on 7/10/2025 by MarketBeat.com Staff
    From Our Partners